Cusato, J.; Bertani, L.; Antonucci, M.; Tomasello, C.; Caviglia, G.P.; Dibitetto, S.; Massano, A.; Mangia, M.; Mula, J.; Ceccarelli, L.;
et al. Vitamin D-Related Genetics as Predictive Biomarker of Clinical Remission in Adalimumab-Treated Patients Affected by Crohn’s Disease: A Pilot Study. Pharmaceuticals 2021, 14, 1230.
https://doi.org/10.3390/ph14121230
AMA Style
Cusato J, Bertani L, Antonucci M, Tomasello C, Caviglia GP, Dibitetto S, Massano A, Mangia M, Mula J, Ceccarelli L,
et al. Vitamin D-Related Genetics as Predictive Biomarker of Clinical Remission in Adalimumab-Treated Patients Affected by Crohn’s Disease: A Pilot Study. Pharmaceuticals. 2021; 14(12):1230.
https://doi.org/10.3390/ph14121230
Chicago/Turabian Style
Cusato, Jessica, Lorenzo Bertani, Miriam Antonucci, Cristina Tomasello, Gian Paolo Caviglia, Simone Dibitetto, Alessandro Massano, Michela Mangia, Jacopo Mula, Linda Ceccarelli,
and et al. 2021. "Vitamin D-Related Genetics as Predictive Biomarker of Clinical Remission in Adalimumab-Treated Patients Affected by Crohn’s Disease: A Pilot Study" Pharmaceuticals 14, no. 12: 1230.
https://doi.org/10.3390/ph14121230
APA Style
Cusato, J., Bertani, L., Antonucci, M., Tomasello, C., Caviglia, G. P., Dibitetto, S., Massano, A., Mangia, M., Mula, J., Ceccarelli, L., Costa, F., Zanzi, F., Astegiano, M., Ribaldone, D. G., & D’Avolio, A.
(2021). Vitamin D-Related Genetics as Predictive Biomarker of Clinical Remission in Adalimumab-Treated Patients Affected by Crohn’s Disease: A Pilot Study. Pharmaceuticals, 14(12), 1230.
https://doi.org/10.3390/ph14121230
